Captis Pharmacy Breakout: Maximize Your Financial and Operational Value

Prior Lake, MN US
May 7, 2024

The Captis Pharmacy Breakout features three separate sessions with speaker panels representing Captis Pharmacy members, health-system pharmacy leaders, and the pharmacy supplier community.  Content will focus on navigating the current challenges and opportunities related to: biosimilar integration, drug shortages, and the Inflation Reduction Act.

Target Audience

  • Healthcare Executives
  • Pharmacists
  • Pharmacy Technicians
  • Other Healthcare Professionals

Learning Objectives

Pharmacists

At the conclusion of this activity, pharmacists should be able to:

  • Discuss the financial challenges and external forces health systems face with integrating biosimilars into existing frameworks.
  • Identify key operational barriers to the adoption of biosimilars with different health systems.
  • Gain insights into the dynamics influencing biosimilar integration from a supplier perspective.
  • Examine the market opportunities presented by biosimilars and their potential impact within health systems including patients, providers, suppliers, and payers.
  • Define the key provisions and goals of the Inflation Reduction Act
  • Analyze the potential benefits of the Inflation Reduction Act in stabilizing prices and fostering economic growth
  • Evaluate the potential drawbacks or challenges associated with implementing the Inflation Reduction Act
  • Facilitate informed discussions on the potential trade-offs and considerations involved in enacting the Inflation Reduction Act
  • Describe the current landscape of drug shortages highlight specific challenges
  • Assess the consequences of drug shortages on patient outcomes and healthcare professionals
  • Provide insight on successful strategies to mitigate the impact of drug shortages

 

Pharmacy Technicians

At the conclusion of this activity, pharmacy technicians should be able to:

  • Discuss the financial challenges and external forces health systems face with integrating biosimilars into existing frameworks.
  • Identify key operational barriers to the adoption of biosimilars with different health systems.
  • Gain insights into the dynamics influencing biosimilar integration from a supplier perspective.
  • Examine the market opportunities presented by biosimilars and their potential impact within health systems including patients, providers, suppliers, and payers.
  • Define the key provisions and goals of the Inflation Reduction Act
  • Analyze the potential benefits of the Inflation Reduction Act in stabilizing prices and fostering economic growth
  • Evaluate the potential drawbacks or challenges associated with implementing the Inflation Reduction Act
  • Facilitate informed discussions on the potential trade-offs and considerations involved in enacting the Inflation Reduction Act
  • Describe the current landscape of drug shortages highlight specific challenges
  • Assess the consequences of drug shortages on patient outcomes and healthcare professionals
  • Provide insight on successful strategies to mitigate the impact of drug shortages
Course summary
Available credit: 
  • 2.25 ACPE Pharmacist
  • 2.25 ACPE Pharmacy Technician
  • 2.25 General CE - Attendance
Course opens: 
05/07/2024
Course expires: 
07/06/2024
Event starts: 
05/07/2024 - 8:00am CDT
Event ends: 
05/07/2024 - 10:45am CDT
Add to calendar: 
Mystic Lake Casino Hotel
2400 Mystic Lake Blvd
Anoka Room
Prior Lake, MN 55372
United States

FACULTY & PLANNERS

Faculty

Wendy Biese, PharmD, MBA, DPLA
Director, Pharmacy
ThedaCare, Inc.

Sara J. Erickson, PharmD
Senior Pharmacy Specialist
Mayo Clinic

Adam Ewald, PharmD, MHA
Sr. Pharmaceutical Contract Portfolio Manager
Mayo Clinic

Matthew Flink, MBA
Director, Pharmacy Administration
Endeavor Health 

Mary Gilmer, PharmD, MHA, BCPS
Director of Pharmaceutical Procurement and Supply
Mayo Clinic 

Michelle Holm, PharmD, MHA, BCPS
Senior Pharmaceutical Contract Portfolio Manager
Mayo Clinic

Nate Leedahl, PharmD, BCPS
Manager, Health System Pharmacy
Sanford Health        

Robert Lucas, PharmD, MBA, BCPS, FASHP
Director of Pharmacy
Blount Memorial Hospital

Lauren Neves, JD
Vice President, Policy and Research
PhRMA

James Semrad
Vice President Service Line Growth/Strategy& Pharmacy
ProHealth Care

Jenna Stern, JD
AVP, Regulatory Affairs and Public Policy
Vizient, Inc.

Cos Trifonidis, MBA
Director, US Biosimilars- IDN/Hospital/Federal Strategy
Organon
 

Planning Committee

Andy Hart, PharmD, RPh
Pharmacy Executive
Captis | Strategic Sourcing Partnerships and Programs
Vizient, Inc.
 
Samantha Gordon, MS 
CE Programs Manager              
Vizient, Inc.

Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director, Continuing Education       
Vizient, Inc.
 

DISCLOSURE
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
Disclosure Statements
 
Absence of Relevant Financial Relationships
 
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
Statement of Content Validity
 
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

 

Joint Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement(s)

Pharmacists (CPE)

Vizient, Inc. designates this live activity for a maximum of 2.25 contact hours for Pharmacists.
 
Universal Activity Number: JA0006103-0000-24-063-L04-P
 
Pharmacy Technicians (CPE)
 
Vizient, Inc. designates this live activity for a maximum of 2.25 contact hours for pharmacy technicians.
 
Universal Activity Number: JA0006103-0000-24-063-L04-P
 
Other Healthcare Professionals (General CE Credit)
 
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation.  Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

 

Available Credit

  • 2.25 ACPE Pharmacist
  • 2.25 ACPE Pharmacy Technician
  • 2.25 General CE - Attendance
Please login or register to take this course.

 

Select the “Obtain Credit” button to access the activity evaluation and to claim CE Credit.
 
Please Note: 
  • If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
  • This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.
Please click here to enter the code you received at the end of the activity to verify your attendance if you have not already done so: https://continuingeducation.vizientinc.com/code

 

 

Required Hardware/software

 

The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.